ANTITUMOR AGENTS .167. SYNTHESIS AND STRUCTURE-ACTIVITY CORRELATIONS OF THE CYTOTOXIC ANTHRAQUINONE 4-BIS-(2,3-EPOXYPROPYLAMINO)-9,10-ANTHRACENEDIONE, AND OF RELATED-COMPOUNDS
Mg. Johnson et al., ANTITUMOR AGENTS .167. SYNTHESIS AND STRUCTURE-ACTIVITY CORRELATIONS OF THE CYTOTOXIC ANTHRAQUINONE 4-BIS-(2,3-EPOXYPROPYLAMINO)-9,10-ANTHRACENEDIONE, AND OF RELATED-COMPOUNDS, Bioorganic & medicinal chemistry, 5(8), 1997, pp. 1469-1479
,4-Bis-(2,3-epoxypropylamino)-9,10-anthracenedione (3) was synthesized
in this laboratory and was found to be a patent antitumor agent. Deri
vatives of this compound containing anthraquinone, naphthoquinone, and
quinone skeletons were also prepared and evaluated for in vitro cytot
oxic activity in several cell lines. These molecules were designed as
bifunctional antitumor agents with the potential to act as (1) interca
lating agents due to their planar backbones, and (2) alkylating agents
due to the presence of alkylating moieties in their side chains. Comp
ounds with an anthraquinone skeleton and propylamino side chains conta
ining epoxides or halohydrins as the alkylating species showed greater
activity than similar compounds with naphthoquinone or quinone skelet
ons. Compounds without these alkylating functionalities (e.g., with al
kene or amino groups) were generally inactive. Hydroxy substitution on
the planar skeleton in conjunction with alkylating side chains gave c
ompounds with the most potent cytotoxic activity. The position of the
hydroxy groups and side chains could be varied without substantially a
ffecting activity. Activity was retained when an epoxypropyloxy side c
hain was substituted for the epoxypropylamino side chain in the parent
compound. (C) 1997 Elsevier Science Ltd.